Article
Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway.
American journal of physiology. Lung cellular and molecular physiology - 1 Mar 2022
Shaughnessy Ciaran A, Yadav Sangya, Bratcher Preston E, Zeitlin Pamela L
Abstract excerpt
Cystic fibrosis (CF) is a genetic disease caused by mutations of the gene encoding a cAMP-activated Cl- channel, the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR modulator therapies consist of small-molecule drugs that rescue mutant CFTR. Regimens of single or combinations of CFTR modulators still rely on endogenous levels of cAMP to regulate CFTR activity. We investigated CFTR activation by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
